$140.37
−0.39%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$140.84
From 52W high−16.75%
Volume2.23M
Market cap$266.80B
P/E (TTM)21.1x
P/S (TTM)4.8x
Div yield2.20%
Key dataSep 18, 2026
Open
$140.84
From 52W high
−16.75%
Volume
2.23M
Market cap
$266.80B
ValuationView details →
P/E (Fwd)
14.9x
EV/EBITDA
13.9x
P/E (TTM)
21.1x
RSI (14)
37.2
MomentumView details →
1D Return
−0.39%
YTD Return
+1.42%
SummaryUpdated Jun 1, 2026
Novartis AG (NYSE:NVS) is a Swiss multinational pharmaceutical corporation founded in 1996 through the merger of Ciba-Geigy and Sandoz. Headquartered in Basel, Switzerland, Novartis has evolved into one of the world's largest pharmaceutical companies, focusing on innovative prescription medicines across multiple therapeutic areas. The company completed a significant strategic transformation in 2023 by spinning off its generics division Sandoz, allowing it to focus entirely on developing and commercializing breakthrough treatments for serious diseases.
Similar companies
Latest newsMore news →
Novartis received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for COSENTYX for the treatment of polymyalgia rheumatica (PMR).2d agoNestlé Japan is expanding its nutrition food business for elderly people by broadening distribution beyond medical institutions, mainly to drugstores, and increasing flavor varieties to capture home-care demand.2d ago